combination

Cyient Semiconductors Acquires Majority Stake in Kinetic Technologies to Drive Custom Power IC Leadership for Edge AI and High-Performance Compute Markets

HYDERABAD, India, Dec. 19, 2025 /PRNewswire/ -- Cyient Semiconductors has signed a definitive agreement to acquire a majority stake in…

1 day ago

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…

6 days ago

NETFLIX TO ACQUIRE WARNER BROS. FOLLOWING THE SEPARATION OF DISCOVERY GLOBAL FOR A TOTAL ENTERPRISE VALUE OF $82.7 BILLION (Equity Value of $72.0 Billion)

Transaction Unites Warner Bros.' Iconic Franchises and Storied Libraries with Netflix's Leading Entertainment Service, Creating an Extraordinary Offering for ConsumersNetflix to…

2 weeks ago

Signing Day Sports Shareholder Letter Details AI/HPC Infrastructure Opportunity with BlockchAIn Digital Infrastructure

SCOTTSDALE, AZ, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American:…

2 weeks ago

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

November 26, 2025 19:00 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27,…

3 weeks ago

FP Markets Wins Global Broker of the Year at the Finance Magnates Awards 2025

SYDNEY, Nov. 11, 2025 /PRNewswire/ -- FP Markets has been recognised with three prestigious distinctions at the Finance Magnates Awards 2025, including…

1 month ago

Armada Acquisition Corp. II Announces Ticker Symbol to Change to XRPN on Oct 30, 2025

New ticker aligns with new $1 billion strategy for XRP exposure on NASDAQ MIAMI, Oct. 29, 2025 /PRNewswire/ -- Armada Acquisition…

2 months ago

Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc

Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolismRobust…

2 months ago

HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress

The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies…

2 months ago

XED Welcomes Back Technology Visionary Mrinal Srivastava as Chief Technology Officer

NEW YORK and MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- XED is proud to announce the return of Mrinal Srivastava as…

3 months ago